ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)
מצבים רפואיים
Pulmonary Tuberculosis (TB)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
National Tuberculosis and Leprosy Training Centre, Saye, Zaria, Kaduna State, Nigeria
Eunice Jiya, MD (Sub-investigator)Federal Teaching Hospital, Katsina, Katsina State, Nigeria
Taofeek Oloyede, MD (Sub-investigator)Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Osun state, Nigeria, Ile-Ife, Osun State, Nigeria
Contact: Study coordinator (Olanisun O Adewole, MD) · adewolef@yahoo.co.uk , ola.adewole@oauife.edu.ng · +2348034074930Contact: Principal Investigator (Olanisun O Adewole, MD)Bolanle A Omotoso, MD (Sub-investigator)Olayemi F Awopeju, MD (Sub-investigator)Olugbenga Ayoola, MD (Sub-investigator)
מובילי המחקר
Olanisun O Adewole, MD
Principal Investigator
Obafemi Awolowo University / Teaching Hospital, Ile Ife, Nigeria
Bolanle A Omotoso, MD
Study Director
Obafemi Awolowo University /Teaching Hospital, Ile- Ife, Osun State, Nigeria
Olanisun O Adewole, MD
Study Chair
Obafemi Awolowo University /Teaching Hospital, Ile- Ife, Osun State, Nigeria